BIOMAT Database Logo BIOMAT Database Logo

6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis. 2007

E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain. emocio@usal.es

Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic analysis of Waldenström macroglobulinemia (WM), but the potential impact of molecular cytogenetics on disease evolution and as a prognostic marker is still unknown. Deletion of the long arm of chromosome 6 (6q-) is the most frequent cytogenetic abnormality in WM. This study analysed the prevalence of this aberration in 102 WM patients, and correlated it with disease characteristics. The incidence of 6q21 deletion was 7% by conventional cytogenetics and 34% when analysed by FISH (54% when cytoplasmic immunoglobulin M-FISH was used). Patients with deletion of 6q displayed features of adverse prognosis, such as higher levels of beta2-microglobulin and monoclonal paraprotein and a greater tendency to display anaemia and hypoalbuminemia. Interestingly, there was a correlation between the presence of 6q deletion and the International Staging System prognostic index (incidence of 6q- among patients stratified in stages 1, 2 and 3 was 24%, 42% and 67% respectively). Those patients diagnosed with smouldering WM who displayed the abnormality showed a trend to an earlier requirement of treatment. Finally, the survival analysis did not show differences between the two groups of patients, probably due to the short follow up of our series.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008258 Waldenstrom Macroglobulinemia A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity. Lymphoma, Lymphoplasmacytoid,Macroglobulinemia,Familial Waldenstrom's Macroglobulinaemia,Lymphoma, Lymphocytic, Plasmacytoid,Primary Macroglobulinemia,Waldenstrom's Macroglobulinaemia,Waldenstrom's Macroglobulinemia,Familial Waldenstrom Macroglobulinaemia,Familial Waldenstroms Macroglobulinaemia,Lymphomas, Lymphoplasmacytoid,Lymphoplasmacytoid Lymphoma,Lymphoplasmacytoid Lymphomas,Macroglobulinaemia, Familial Waldenstrom's,Macroglobulinaemia, Waldenstrom's,Macroglobulinemia, Primary,Macroglobulinemia, Waldenstrom,Macroglobulinemia, Waldenstrom's,Waldenstrom Macroglobulinaemia,Waldenstrom's Macroglobulinaemia, Familial,Waldenstroms Macroglobulinaemia,Waldenstroms Macroglobulinemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D003582 Cytogenetics A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE. Cytogenetic
D005260 Female Females

Related Publications

E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation.
November 2022, Haematologica,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.
January 2018, BioMed research international,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia.
January 2014, BioMed research international,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
September 2006, Cancer genetics and cytogenetics,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Waldenström macroglobulinemia with karyotypic aberrations involving both homologous 6q.
January 2001, Cancer genetics and cytogenetics,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Analysis of 6q deletion in Waldenstrom macroglobulinemia.
September 2007, European journal of haematology,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Agranulocytosis Associated with Waldenström Macroglobulinemia.
January 2018, Acta haematologica,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
Kidney diseases associated with Waldenström macroglobulinemia.
October 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
CNS Vasculitis Associated with Waldenström Macroglobulinemia.
January 2016, Case reports in neurological medicine,
E M Ocio, and R F J Schop, and B Gonzalez, and S A Van Wier, and J M Hernandez-Rivas, and N C Gutierrez, and R Garcia-Sanz, and M J Moro, and C Aguilera, and J Hernandez, and R Xu, and P R Greipp, and A Dispenzieri, and S M Jalal, and M Q Lacy, and N Gonzalez-Paz, and M A Gertz, and J F San Miguel, and R Fonseca
What is Waldenström macroglobulinemia?
November 2013, Leukemia & lymphoma,
Copied contents to your clipboard!